Logo image of GWAV

GREENWAVE TECHNOLOGY SOLUTIO (GWAV) Stock Fundamental Analysis

NASDAQ:GWAV - Nasdaq - US57630J4031 - Common Stock

0.42  -0.03 (-5.83%)

Fundamental Rating

2

Taking everything into account, GWAV scores 2 out of 10 in our fundamental rating. GWAV was compared to 83 industry peers in the Commercial Services & Supplies industry. GWAV may be in some trouble as it scores bad on both profitability and health. GWAV has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

GWAV had negative earnings in the past year.
In the past year GWAV has reported a negative cash flow from operations.
In the past 5 years GWAV reported 4 times negative net income.
GWAV had a negative operating cash flow in each of the past 5 years.
GWAV Yearly Net Income VS EBIT VS OCF VS FCFGWAV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20M -40M -60M -80M -100M

1.2 Ratios

GWAV has a worse Return On Assets (-123.92%) than 97.56% of its industry peers.
GWAV has a Return On Equity of -168.15%. This is amonst the worse of the industry: GWAV underperforms 87.80% of its industry peers.
Industry RankSector Rank
ROA -123.92%
ROE -168.15%
ROIC N/A
ROA(3y)-73.03%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GWAV Yearly ROA, ROE, ROICGWAV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20K -40K -60K -80K -100K

1.3 Margins

GWAV has a Gross Margin (37.21%) which is in line with its industry peers.
In the last couple of years the Gross Margin of GWAV has declined.
GWAV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 37.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-25.95%
GM growth 5Y-16.49%
GWAV Yearly Profit, Operating, Gross MarginsGWAV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200K -400K -600K -800K -1M

3

2. Health

2.1 Basic Checks

GWAV does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for GWAV has been reduced compared to 1 year ago.
The number of shares outstanding for GWAV has been reduced compared to 5 years ago.
GWAV has a worse debt/assets ratio than last year.
GWAV Yearly Shares OutstandingGWAV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
GWAV Yearly Total Debt VS Total AssetsGWAV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of -9.54, we must say that GWAV is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -9.54, GWAV is doing worse than 95.12% of the companies in the same industry.
GWAV has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of GWAV (0.09) is better than 78.05% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Altman-Z -9.54
ROIC/WACCN/A
WACC7.56%
GWAV Yearly LT Debt VS Equity VS FCFGWAV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M -20M -30M

2.3 Liquidity

A Current Ratio of 1.52 indicates that GWAV should not have too much problems paying its short term obligations.
GWAV has a Current ratio (1.52) which is comparable to the rest of the industry.
A Quick Ratio of 1.36 indicates that GWAV should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.36, GWAV is in line with its industry, outperforming 52.44% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.52
Quick Ratio 1.36
GWAV Yearly Current Assets VS Current LiabilitesGWAV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

3

3. Growth

3.1 Past

The earnings per share for GWAV have decreased by -8.64% in the last year.
The Revenue has been growing slightly by 3.88% in the past year.
Measured over the past years, GWAV shows a very strong growth in Revenue. The Revenue has been growing by 346.94% on average per year.
EPS 1Y (TTM)-8.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.9%
Revenue 1Y (TTM)3.88%
Revenue growth 3Y1427.89%
Revenue growth 5Y346.94%
Sales Q2Q%3.98%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GWAV Yearly Revenue VS EstimatesGWAV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
GWAV Yearly EPS VS EstimatesGWAV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 -1K -2K -3K -4K -5K

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GWAV. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GWAV Price Earnings VS Forward Price EarningsGWAV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GWAV Per share dataGWAV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -50 -100 -150 -200 -250

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

GWAV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

GREENWAVE TECHNOLOGY SOLUTIO

NASDAQ:GWAV (1/22/2025, 2:40:45 PM)

0.42

-0.03 (-5.83%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)11-12 2024-11-12
Earnings (Next)04-14 2025-04-14
Inst Owners11.54%
Inst Owner Change0%
Ins Owners12.87%
Ins Owner Change48.61%
Market Cap9.40M
AnalystsN/A
Price TargetN/A
Short Float %7.74%
Short Ratio0.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.28
P/FCF N/A
P/OCF N/A
P/B 0.18
P/tB 0.28
EV/EBITDA N/A
EPS(TTM)-286.8
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.09
FCFYN/A
OCF(TTM)-0.63
OCFYN/A
SpS1.52
BVpS2.29
TBVpS1.5
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -123.92%
ROE -168.15%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 37.21%
FCFM N/A
ROA(3y)-73.03%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-25.95%
GM growth 5Y-16.49%
F-Score3
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 151.86%
Cap/Sales 30.67%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.52
Quick Ratio 1.36
Altman-Z -9.54
F-Score3
WACC7.56%
ROIC/WACCN/A
Cap/Depr(3y)243.33%
Cap/Depr(5y)N/A
Cap/Sales(3y)8.38%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.9%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.88%
Revenue growth 3Y1427.89%
Revenue growth 5Y346.94%
Sales Q2Q%3.98%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-56.19%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-202.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-235.79%
OCF growth 3YN/A
OCF growth 5YN/A